Month: June 2024

Nasdaq Closing Cross continues to play an integral and innovative role in capital markets Global growth in trading volumes demands increasingly scalable and flexible technology architecture NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) — Nasdaq, Inc. (Nasdaq: NDAQ) today announced the Nasdaq Closing Cross had a record day as it was used to rebalance Nasdaq-listed securities in the entire family of Russell US Indexes, part of global index provider FTSE Russell, during its annual reconstitution. This year marks the 40th anniversary of the Russell 3000® Index and the 21st year that the Closing Cross has been used to calculate the Russell Reconstitution. 2,899,191,109 shares, representing a record $95.257 billion, were executed in the Closing Cross in 0.878 seconds across Nasdaq-listed securities, representing the largest liquidity event...

BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) — LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”). The shareholders approved, by a majority of votes, resolutions to elect each of the following directors: Diane Beaudry Frank J. DellaFera Stuart W. Fowler Pierre LafrenièreMario Paradis François RobergeJoseph Soccodato In addition, the shareholders of the Company, by a majority of votes, proceeded with the appointment of KPMG LLP as auditors of the Corporation, authorized the directors to fix their remuneration and approved the 10% rolling stock option plan of the Corporation. Mr. François Roberge, Chairman of the Board, commented:...

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES SASKATOON, Saskatchewan, June 28, 2024 (GLOBE NEWSWIRE) — GFG Resources Inc. (TSXV: GFG) (OTCQB: GFGSF) (“GFG” or the “Company”) announces that it proposes to further amend the common share purchase warrants (“Warrants”) of the Company originally issued on October 6, 2022, March 21, 2023 and April 19, 2024 (the “Proposed Amendments“). An aggregate of 5,692,359 Warrants were issued on October 6, 2022; 12,379,150 Warrants were issued on March 21, 2023; and 12,561,345 Warrants were issued on April 19, 2024. As previously announced, the terms of the Warrants originally issued on October 6, 2022 and March 21, 2023 were recently amended to extend the expiry date to April 19, 2027, as well as to amend the exercise price to $0.13. The Proposed Amendments will...

MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, reported results for the fiscal year ended March 31, 2024. All comparisons are to the same year-ago period unless otherwise noted. The company will hold a conference call at 5:00 p.m. Eastern time today to discuss the results (see dial-in information below). Fiscal 2024 Financial HighlightsRevenues up 6% to $969,000, driven sales of the company’s lead veterinary medical device, Spryng™ with OsteoCushion™ technology. Revenue growth was driven largely by the company’s expanded distributor network, with sales to distributors increasing 15% to $732,000. Gross profit increased 6% to $740,000. Gross margin improved...

BETHESDA, Md., June 28, 2024 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announces that interim-CEO and current CFO Gene Mack will host a business and corporate update call on Monday, July 1, 2024, beginning 8:30am ET pre-market open. Participants can join the conference call through the News and Events section of the Company website at https://www.gaintherapeutics.com/investors-media/news-events. A recorded version and transcript of the call will be archived and available for replay in the News and Events section of the Company website within 24 hours after the event. About Gain Therapeutics, Inc. Gain Therapeutics, Inc. is a clinical-stage biotechnology...

Nokia CorporationStock Exchange Release28 June 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 28.06.2024 Espoo, Finland – On 28 June 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 439,914 3.55CEUX – –BATE – –AQEU – –TQEX – –Total 439,914 3.55* Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation...